Bank of America
ALXA

Bank of America’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Bank of America’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,707
Closed -$1K – 7653
2016
Q1 		$1K Buy
2,707
+707
+35% +$309 ﹤0.01% 6923
2015
Q4 		$1K Hold
2,000
– – ﹤0.01% 7245
2015
Q3 		$2K Buy
+2,000
New +$2.34K ﹤0.01% 7012
2014
Q1 		– Sell
-58
Closed – – 8395
2013
Q4 		$0 Sell
58
-1,442
-96% -$7.08K ﹤0.01% 8382
2013
Q3 		$8K Buy
+1,500
New +$7.06K ﹤0.01% 7263

Bank of America's ALXA Position: Q2 2016 in Review

Bank of America sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 2,707 shares — an estimated $1K sold.

Bank of America first reported a position in ALXA in Q3 2013 and held it in 5 quarters. The position peaked at $8K in Q3 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Bank of America reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Bank of America sold 2,707 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $1K.
  • Bank of America first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 5 quarters.
  • Bank of America's Alexza Pharmaceuticals Inc position peaked at $8K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Bank of America's 13F filing for Q2 2016, filed 15 Aug 2016.